Genetic Landscape of Somatic Mutations in a Large Cohort of Sporadic Medullary Thyroid Carcinomas Studied by Next-Generation Targeted Sequencing-Reference-Cited by-同舟云学术

Genetic Landscape of Somatic Mutations in a Large Cohort of Sporadic Medullary Thyroid Carcinomas Studied by Next-Generation Targeted Sequencing

Published:2019-10 Issue: Volume:20 Page:324-336
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Ciampi Raffaele^ORCID,Romei Cristina,Ramone Teresa,Prete Alessandro,Tacito Alessia,Cappagli Virginia,Bottici Valeria,Viola David,Torregrossa Liborio,Ugolini Clara,Basolo Fulvio,Elisei Rossella

Funder

Associazione Italiana per la Ricerca sul Cancro

Agenzia Italiana del Farmaco

Progetto di Ricerca di Ateneo

University of Pisa

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference42 articles.

1. Exomic sequencing of medullary thyroid cancer reveals dominant and mutually exclusive oncogenic mutations in RET and RAS;Agrawal;J. Clin. Endocrinol. Metab.,2013

2. TERT promoter mutations in thyroid cancer;Alzahrani;Horm. Cancer,2016

3. The emerging clinical relevance of genomics in cancer medicine;Berger;Nat. Rev. Clin. Oncol.,2018

4. Somatic RAS mutations occur in a large proportion of sporadic RET-negative medullary thyroid carcinomas and extend to a previously unidentified exon;Boichard;J. Clin. Endocrinol. Metab.,2012

5. Acquired resistance to TKIs in solid tumours: learning from lung cancer;Camidge;Nat. Rev. Clin. Oncol.,2014

Cited by 148 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fundamentals and recent advances in the evaluation and management of medullary thyroid carcinoma;Molecular and Cellular Endocrinology;2024-10

2. Thyroid Malignancy and Cutaneous Lichen Amyloidosis: Key Points Amid RET Pathogenic Variants in Medullary Thyroid Cancer/Multiple Endocrine Neoplasia Type 2 (MEN2);International Journal of Molecular Sciences;2024-09-10

3. Molecular Profiling of Low-Risk Papillary Thyroid Carcinoma (mPTC) on Active Surveillance;The Journal of Clinical Endocrinology & Metabolism;2024-08-26

4. Mechanisms of resistance to tyrosine kinase inhibitor‐targeted therapy and overcoming strategies;MedComm;2024-08-24

5. Minor role of TP53 and TERT promoter mutations in medullary thyroid carcinoma: report of new cases and revision of the literature;Endocrine;2024-08-23